3 Health Services Stocks Moving The Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 72 points (0.4%) at 16,112 as of Thursday, Feb. 20, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,810 issues advancing vs. 1,095 declining with 165 unchanged.

The Health Services industry currently sits up 0.5% versus the S&P 500, which is up 0.3%. Top gainers within the industry include Icon ( ICLR), up 7.4%, Parexel International Corporation ( PRXL), up 3.3%, Varian Medical Systems ( VAR), up 2.5%, PerkinElmer ( PKI), up 2.0% and Agilent Technologies ( A), up 1.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.61 (0.8%) to $82.25 on light volume. Thus far, 558,689 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $81.18-$82.39 after having opened the day at $81.61 as compared to the previous trading day's close of $81.64.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $31.2 billion and is part of the health care sector. Shares are up 8.7% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate Stryker Corporation a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, HCA Holdings ( HCA) is up $0.38 (0.8%) to $49.94 on light volume. Thus far, 361,158 shares of HCA Holdings exchanged hands as compared to its average daily volume of 2.7 million shares. The stock has ranged in price between $49.30-$49.98 after having opened the day at $49.60 as compared to the previous trading day's close of $49.56.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $22.3 billion and is part of the health care sector. Shares are up 3.9% year-to-date as of the close of trading on Wednesday. Currently there are 15 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Thermo Fisher Scientific ( TMO) is up $2.20 (1.8%) to $124.01 on average volume. Thus far, 1.6 million shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $122.49-$124.67 after having opened the day at $124.33 as compared to the previous trading day's close of $121.81.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $44.6 billion and is part of the health care sector. Shares are up 11.0% year-to-date as of the close of trading on Wednesday. Currently there are 14 analysts who rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Thermo Fisher Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs